The Effect of Biomicroscope Illumination System on Grading Anterior Chamber Inflammation

Purpose To determine how a biomicroscope illumination system affects the grading of anterior chamber (AC) inflammation. Design Laboratory investigation. Methods An artificial AC was designed to replicate optically a human AC and was filled with 5-μm polystyrene beads suspended in ethanol. A high-def...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology Vol. 148; no. 4; pp. 516 - 520.e2
Main Authors: Wong, Ira G, Nugent, Alex K, Vargas-Martín, Fernando
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 01-10-2009
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To determine how a biomicroscope illumination system affects the grading of anterior chamber (AC) inflammation. Design Laboratory investigation. Methods An artificial AC was designed to replicate optically a human AC and was filled with 5-μm polystyrene beads suspended in ethanol. A high-definition video eyepiece camera recorded the moving beads. Using image processing software, the main outcomes measures determined were the average number of beads in a 1 × 1-mm field at varying widths of the slit-beam. Results The volume of light and number of beads observed increased significantly as the slit-beam widened. Additionally, 3 separate biomicroscopes of identical make and model were found to produce different levels of luminance at the same aperture dial settings, influencing the number of beads observed, with the brighter biomicroscope yielding higher bead counts. Conclusions Ability to count beads and perhaps the ability to count inflammatory cells in an inflamed eye depend on a number of factors, including the level of illumination and width of the slit-beam. This study demonstrated that the brighter the illumination and the wider the beam, the more beads were observed. This illustrates the importance of standardizing biomicroscopy, particularly where consecutive observations are used to make clinical decisions and in cases of multicenter clinical trials where clinical data are evaluated across different facilities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2009.04.027